Skip to main content
. 2015 Jun;7(3):125–134. doi: 10.1177/1756287215577329

Figure 3.

Figure 3.

Median serum prostate specific antigen (PSA) levels (ng/ml) in patients receiving triptorelin pamoate (11.25 mg) by the subcutaneous route (ITT population) at baseline and week 13.

Arrows denote when triptorelin injections were administered.

ITT, intention-to-treat.